NEW

GE HealthCare Preps for SIR 2024

GE HealthCare will showcase its latest technologies in image guiding solutions, surgery, ultrasound and CT-navigation at the upcoming 2024 Society of Interventional Radiology (SIR) Annual Scientific Meeting taking place March 23-28 in Salt Lake City, Utah. The...

Samsung Accepts Healthcare Innovator Award

Boston Imaging, the United States headquarters of Samsung’s digital radiography and ultrasound business, was awarded HHM Health’s Healthcare Innovator Award

AHRA Co-Founder Passes Away

On March 2, 2024, Louise Broadley passed away at 101 years old. AHRA shared the news via an email and website post that reads, “She was a noble woman, who not only achieved many milestones within the imaging profession, but likewise paved the way for aspiring leaders...

Artificial Intelligence Paper Outlines FDA’s Approach to Protect Public Health and Promote Ethical Innovation

Today, the U.S. Food and Drug Administration (FDA) released its “Artificial Intelligence and Medical Products: How CBER, CDER, CDRH, and OCP are Working Together,” which outlines how FDA’s medical product centers are working together to protect public health while...

MITA Commends Efforts to Establish DBT Screening Coverage for TRICARE Beneficiaries

The Medical Imaging & Technology Alliance (MITA) applauded a bipartisan and bicameral group of lawmakers for introducing the Better and Robust Screening Today Act (H.R. 5238/ S. 2944). Led by Senator Martha McSally (R-AZ), Senator Jeanne Shaheen (D-NH), Congresswoman Chrissy Houlahan (D-PA) and Congresswoman Elise Stefanik (R-NY), this legislation would establish TRICARE coverage for Digital Breast Tomosynthesis (DBT) screening mammography. This is an innovative diagnostic technology that has proven to be more effective than traditional mammography, especially for women with dense breast tissue or who are at high risk for breast cancer.

“MITA applauds the introduction of the Better and Robust Screening Today Act, which will ensure our nation’s servicewomen have the coverage necessary to receive the right breast cancer diagnostic technology for them,” said Patrick Hope, executive director of MITA. “We will continue to support these ongoing efforts and commend lawmakers for fighting to ensure that former and current members of the U.S. military whose mammograms show they have dense breast tissue have access to the same advanced screening options as those with private insurance, Medicare, and Medicaid.”

According to the Mayo Clinic, about half of women undergoing mammograms have dense breasts.

Earlier this year, Congress passed a law mandating mammography providers to notify patients with dense breast tissue so they can be recommended for further screening. Currently, TRICARE covers DBT for diagnostic follow-up screening, but not for the initial scan. TRICARE is the only national payer not covering screening DBT. Having access to state-of-the-art imaging for screening ensures that abnormalities are detected earlier, particularly for women with dense breasts where they may be missed with traditional mammography, and secondary tests aren’t recommended.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

Open